BIONET Corp.
Research BIONET Corp. (1784.TWO) on Bullrun: market cap TWD 2.94B, P/E 50.0, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1784.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyTWD
- Market capTWD 2.94B
- P/E50.0
- Dividend yield2.0%
- Financial periodQ2 2026
- RevenueTWD 338.35M
- Net incomeTWD 19.80M
- Free cash flowTWD 41.08M
- Gross margin57.6%
Valuation Snapshot
latest market cap is TWD 2.94B; P/E is 50.0; dividend yield is 2.0%.
Peer valuation comparison
Latest P/E is 50x versus a Healthcare sector median of 21.8x (129.4% above).
Latest dividend yield is 1.96% versus a Healthcare sector median of 2.4% (18.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.94B | 50.0 | 1.6% | 0.88 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.88 TWD, yield 2.0%.
About BIONET Corp.
BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products.
ETFs that hold BIONET Corp.
US-listed ETFs
BIONET Corp. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BIONET Corp.'s market cap?
BIONET Corp.'s market capitalization is TWD 2.94B.
What is BIONET Corp.'s P/E ratio?
BIONET Corp.'s price-to-earnings (P/E) ratio is 50.0.
Does BIONET Corp. pay a dividend?
BIONET Corp. has a dividend yield of 2.0%.
What does BIONET Corp. do?
BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products.